<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00552877</url>
  </required_header>
  <id_info>
    <org_study_id>SOIV-20070043</org_study_id>
    <nct_id>NCT00552877</nct_id>
  </id_info>
  <brief_title>The SOURT OUT IV TRIAL</brief_title>
  <acronym>SORT OUT IV</acronym>
  <official_title>Randomized Clinical Comparison of the Xience V and the Cypher Coronary Stents in Non-selected Patients With Coronary Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a randomized study the Xience V coroary artery stent may be non inferior to the Cypher
      Select+ coronary stents in the treatment of unselected patients with coronary artery disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      2 Purpose In a randomized study to compare the Cypher Select+ and the Xience V coronary
      stents in the treatment of unselected patients with coronary artery disease.

      2.1 Primary objective In a randomized study to compare the Xience V and the Cypher Select+
      coronary stents by assessing SAFETY (cardiac death, myocardial infarction and/or stent
      thrombosis) and EFFICACY (target vessel revascularization) after 9 months.

      2.2 Secondary objective To compare device success rate, procedure success rate and
      complication rate during hospitalization, after 1 month and after 9 months and the incidence
      of late stent thrombosis after 12, 24 and 36 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SAFETY (cardiac death, myocardial infarction and/or stent thrombosis) EFFICACY (target vessel revascularization)</measure>
    <time_frame>9 months, 1 year, 2 years, 3 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2678</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <condition>Coronary Atherosclerosis</condition>
  <condition>Percutaneous Coronary Intervention</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cypher Select plus stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Xience V stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous coronary intervention (Xience V stent)</intervention_name>
    <description>Cypher Select plus coronary stent Xience V coronary stent</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>Cypher Select plus coronary stent</other_name>
    <other_name>Xience V coronary stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients treated with one or more drug eluting stents in the coronary arteries at
             one of the 5 heart centres in Denmark (Gentofte, Rigshospitalet, Odense, Skejby,
             Aalborg) can be included in the study.

        Exclusion Criteria:

          -  The patient will not participate

          -  The patient participates in other randomised stent studies

          -  Expected survival &lt; 1 year

          -  Allergy to Aspirin, Clopidogrel or Ticlopidine

          -  Allergy to Sirolimus or ABT-578
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per Thayssen, MD DMSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital, Dept. of Cardiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Odense University Hospital, Dept. of Cardiology</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2007</study_first_submitted>
  <study_first_submitted_qc>November 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2007</study_first_posted>
  <last_update_submitted>August 12, 2009</last_update_submitted>
  <last_update_submitted_qc>August 12, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2009</last_update_posted>
  <responsible_party>
    <name_title>Per Thayssen</name_title>
    <organization>Odense University Hospital</organization>
  </responsible_party>
  <keyword>PCI</keyword>
  <keyword>Drug-eluting stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

